Heng-Phon Too's Biography

Heng-Phon Too, Associate Professor, National University of Singapore

Dr Too Heng Phon received his undergraduate training in Biochemistry, Imperial College of Science & Technology, UK. He then continued with his PhD training in a joint research project in Imperial College, Institute of Ophthalmology and West Minister Hospital, London. Thereafter, he received further training in the Medical Research Council, Cambridge (UK), where he was a Procter & Gamble Fellow. He then moved to the Department of Anesthesiology and Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School where he was a recipient of the Merck Sharpe Dohme Academic Development Fellowship. Currently, he is a faculty in the Department of Biochemistry, National University Singapore, a Principal Scientist in the Bioprocess Technological Institute and was a Fellow of the Singapore Massachusetts Institute of Technology Alliance (Molecular Engineering of Biological & Chemical Systems program; Chemical & Pharmaceutical Engineering program). Dr Too is a molecular biologist focusing on biotechnology and neuroscience. In recent years, Roche Diagnostics (USA & Asia Pacific) and National Institute of Health (USA) funded him to develop qPCR assays for infectious diseases. He is an awardee of a number of Commercialization of Technology grants from A*STAR and Singapore-Massachusetts Research & Technology (SMART). Dr Too has recently been awarded a KHIDI-A*STAR grant with a Korean company to co-develop IVD for prognostic/diagnostic of breast cancer. He is the founder of MiRXES and the lead principal investigator of the miRNA profiling facility (µRSIC), A*STAR. He has intellectual property protections on specific diagnostic platforms with various research departments and with Massachusetts Institute of Technology, USA.